BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6782278)

  • 1. [Trial of combination chemotherapy for multiple myeloma and macroglobulinemia--VENAP therapy (author's transl)].
    Furukawa K; Fujiwara Y; Nakaide Y; Tanaka M; Tanaka M; Hirota Y
    Rinsho Ketsueki; 1980 Nov; 21(11):1683-91. PubMed ID: 6782278
    [No Abstract]   [Full Text] [Related]  

  • 2. [An atypical form of Waldenstrom's macroglobulinaemia with complete remission lasting for more than two years after multiple chemotherapy (author's transl)].
    Bierling P; Rochant H; Brun B; Intrator L; Dreyfus B
    Ann Med Interne (Paris); 1979; 130(10):443-7. PubMed ID: 119455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
    Takagi T; Oguro M; Sakai C
    Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case report of macroglobulinemia responded to AAAP-therapy].
    Maruo K; Yoshikawa H; Nagata K
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):733-9. PubMed ID: 6820907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of paraproteinemic hemoblastoses].
    Fereberger W
    Acta Med Austriaca; 1982; 9(4):151-7. PubMed ID: 6814158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
    Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
    Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy].
    Uzuka Y; Saito Y; Takahashi H; Komatsu M; Ito T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2269-73. PubMed ID: 2735769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of multiple myeloma].
    Uzuka Y; Saito Y; Ito T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1481-7. PubMed ID: 2389944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination chemotherapy with vincristine, cyclophosphamide, procarbazine and prednisolone in advanced reticulum cell sarcoma (author's transl)].
    Yoshikawa S; Morishima Y
    Rinsho Ketsueki; 1976 Jul; 17(7):764-9. PubMed ID: 789933
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Ono Y; Saito M; Itou T; Yamamoto K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):863-5. PubMed ID: 2469398
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
    Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
    Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study on the multiple myeloma--especially with respect to the effects of treatments (author's transl)].
    Rinsho Ketsueki; 1980 Nov; 21(11):1698-706. PubMed ID: 7206227
    [No Abstract]   [Full Text] [Related]  

  • 13. The chemotherapy of plasma cell myeloma and related disorders.
    Coleman M; Silver RT
    Antibiot Chemother (1971); 1974; 18():112-47. PubMed ID: 4219116
    [No Abstract]   [Full Text] [Related]  

  • 14. [AAAP-therapy for "hypoplastic" acute non-lymphocytic leukemia (author's transl)].
    Yoshikawa H; Maruo K
    Rinsho Ketsueki; 1979 Dec; 20(12):1642-54. PubMed ID: 295388
    [No Abstract]   [Full Text] [Related]  

  • 15. [The study of VENP therapy for acute lymphocytic leukemia (author's transl)].
    Yoshikawa H; Maruo K; Ichiniya M; Yamada H; Masaoka T; Takeyama H; Kawashima K; Yamada K
    Rinsho Ketsueki; 1980 Jun; 21(6):778-84. PubMed ID: 6936564
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of two combination chemotherapies in previously untreated non Hodgkin's lymphoma.
    Somoza N; Pavlovsky S; Suárez A; Morgenfeld M; Besuschio SC; Bezares R; Quiroga Micheo E; Lein JM; De María H
    Medicina (B Aires); 1981; 41 Suppl():35-43. PubMed ID: 7345350
    [No Abstract]   [Full Text] [Related]  

  • 17. [Four cases of therapy-related leukemia in multiple myeloma].
    Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of malignant gammopathies].
    Emmerich B
    Dtsch Med Wochenschr; 1984 Jan; 109(1):26-30. PubMed ID: 6420138
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chemotherapy of MOPP and C-MOPP resistant cases of malignant lymphoma. (A preliminary report) (author's transl)].
    Kolarić K; Tomek R; Roth A
    Lijec Vjesn; 1980 Jun; 102(6):306-9. PubMed ID: 7453477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.